Altaviva™ Tibial Nerve Stimulation for Urge Urinary Incontinence | Advanced Urology

What Is Altaviva?

Altaviva™ is Medtronic's implantable tibial neuromodulation (ITNM) system — a small device (approximately half the length of a stick of gum) placed just beneath the skin near the ankle. It sends gentle electrical impulses to the posterior tibial nerve, helping restore communication between the bladder and the brain to regulate bladder control.

Unlike external percutaneous tibial nerve stimulation (PTNS) that requires weekly office visits, or sacral neuromodulation (InterStim) that requires a surgical implant in the lower back, Altaviva provides a minimally invasive alternative that delivers therapy automatically around the clock — with virtually no daily patient involvement after implantation.

Altaviva received FDA approval in September 2025 and represents the next generation of tibial nerve stimulation technology, built on Medtronic's decades of neuromodulation expertise.

How Altaviva Works

The Science

The posterior tibial nerve originates from the same spinal segments (S2-S4) that control bladder function. Stimulating this nerve at the ankle sends signals back to the sacral nerve plexus and brainstem, modulating the overactive bladder reflexes that cause urgency and leakage.

  • Reduces involuntary bladder contractions that cause urgency.
  • Restores normal nerve communication between bladder and brain.
  • Improves bladder capacity and decreases voiding frequency.
  • Delivers therapy automatically — no manual activation needed.

Device Features

  • Size: Approximately half the length of a stick of gum; sits below the skin above the fascia near the ankle.
  • Battery Life: Expected 15 years with Medtronic's proprietary Overdrive™ battery technology.
  • Recharging: Only 1-2 times per year under standard settings (~30 minutes per session).
  • MRI Compatibility: Full-body MRI-ready from day one (1.5T and 3T).
  • Therapy Activation: Same-day activation after implant; automatic delivery.
  • Implant Location: Near the ankle, placed through a 2 cm incision along Langer lines.

Who Is a Candidate?

Altaviva is FDA-approved for adults with urge urinary incontinence (UUI) who have not responded adequately to conservative therapies. Ideal candidates include:

  • Urgency urinary incontinence (involuntary leakage with a strong, sudden urge to urinate).
  • Urge-predominant mixed incontinence (urgency component combined with some stress leakage).
  • Patients who have tried and failed behavioral therapy, pelvic floor exercises, or medications.
  • Patients who cannot tolerate OAB medications due to side effects (dry mouth, constipation, cognitive changes).
  • Patients seeking a minimally invasive, long-lasting option before considering sacral neuromodulation (InterStim).

Not ideal for: Patients with pure stress urinary incontinence, urinary retention, or neurogenic bladder from spinal cord injury or multiple sclerosis (consult with your physician for individualized assessment).

The Implantation Procedure

Before the Procedure

  • Complete bladder symptom questionnaires (OAB-q, ICIQ) and voiding diary.
  • Review current medications with your physician — blood thinners may need to be paused.
  • No shaving near or on the ankle 48 hours before the procedure.
  • No fasting or pre-operative clearance required.
  • Procedure is scheduled in the office — no hospital visit needed.

During the Procedure

  • In-office procedure — no sedation or imaging required.
  • Local anesthesia is applied to numb the area near the ankle.
  • A small 2 cm incision is made along natural skin lines (Langer lines) near the medial ankle.
  • Altaviva device is placed above the fascia adjacent to the posterior tibial nerve.
  • Incision closed with sutures; device is not visible externally.
  • Therapy is activated the same day — the device begins working immediately.

Recovery and What to Expect

Immediate Recovery

  • Walk out of the office after the procedure — no recovery room needed.
  • Mild soreness or tenderness at the implant site for a few days (over-the-counter pain relief as needed).
  • Keep the incision clean and dry for 48 hours, then normal showering is fine.
  • Avoid heavy lifting or vigorous exercise for approximately 1 week.
  • Most patients return to work and normal activities the next day.

Symptom Improvement Timeline

  • Day 1: Therapy begins automatically after same-day activation.
  • Weeks 2-6: Many patients begin noticing reduced urgency and fewer leakage episodes.
  • 3 months: Significant improvement typically seen; assessed with questionnaires and voiding diary.
  • 6-12 months: Continued benefit with ongoing automatic therapy delivery.
  • Follow-up visits scheduled to monitor progress and optimize as needed.

Clinical Outcomes (TITAN 2 Pivotal Trial)

80% of patients reported their condition improved at 12 months
61% achieved ≥50% reduction in urge incontinence episodes
70% experienced clinically meaningful improvement in quality of life
15 years expected battery life with Overdrive™ technology

Published Evidence: The TITAN 2 multicenter pivotal trial enrolled 188 patients with urge urinary incontinence who had failed or were not candidates for conservative therapy. Results demonstrated statistically significant improvements in UUI episodes, quality of life, and patient-reported outcomes at 12 months, leading to FDA approval in September 2025.

Altaviva vs. Other OAB / UUI Treatments

  • vs. OAB Medications: Altaviva avoids systemic side effects like dry mouth, constipation, and cognitive changes. Ideal for patients who can't tolerate or don't respond to medications.
  • vs. Weekly PTNS (Urgent PC): Altaviva eliminates the need for weekly 30-minute office visits. Once implanted, therapy is delivered automatically and continuously.
  • vs. eCoin: Both are implantable tibial nerve stimulators near the ankle. Altaviva offers a significantly longer battery life (15 years vs. ~3 years for eCoin), MRI compatibility from day one, and rechargeable technology requiring only 1-2 charges per year.
  • vs. InterStim (Sacral Neuromodulation): Altaviva is less invasive — no surgical implant in the lower back, no general anesthesia, no staged trial procedure. InterStim may offer broader indications (fecal incontinence, retention) and has a longer track record, but requires a more complex surgical process.
  • vs. Botox Injections: Altaviva is reversible and does not carry the risk of urinary retention or need for self-catheterization. Botox requires repeat injections every 6-9 months. Altaviva provides continuous, long-term therapy.

Potential Risks and Considerations

Common Side Effects

  • Mild pain or tenderness at the implant site (typically resolves within a few days to a week).
  • Temporary swelling or bruising near the incision.
  • Mild tingling sensation near the ankle (adjustable with device programming).

Less Common Complications

  • Implant-related infection (~4% in TITAN trial; treated with antibiotics or device removal if needed).
  • Implant site pain persisting beyond initial recovery (~3% in TITAN 2 trial).
  • Device migration or repositioning (rare; may require a minor revision procedure).

Device Management and Recharging

Automatic Therapy Delivery

Unlike some other neuromodulation devices, Altaviva is designed for simplicity — once activated, therapy is delivered automatically without daily patient involvement. There are no manual adjustments needed in your daily routine.

Recharging

  • The Altaviva system uses Medtronic's proprietary Overdrive™ rechargeable battery technology.
  • Under standard settings, recharging is needed only 1-2 times per year.
  • Each recharging session takes approximately 30 minutes using an external charger placed over the ankle.
  • Battery is expected to last up to 15 years — significantly reducing the need for replacement procedures.

MRI Compatibility

  • Altaviva is MRI-ready from the day of implantation — compatible with both 1.5T and 3T full-body MRI scans.
  • No need to deactivate or take special precautions for most imaging studies.
  • Always inform your MRI technologist about your implant and carry your device ID card.

Why Advanced Urology?

  • Full spectrum of bladder treatments — from behavioral therapy and medications to Botox, eCoin, Altaviva, and InterStim, we offer every option so you get the right treatment for your situation.
  • Experienced neuromodulation specialists trained in the latest implantable tibial nerve stimulation technologies.
  • In-office implantation for convenience and comfort — no hospital required.
  • Individualized care — we help you compare all options (Altaviva vs. InterStim vs. Botox) to find the best fit for your symptoms, lifestyle, and goals.
  • Long-term support — ongoing follow-up, device management, and symptom optimization.
  • 12 convenient Metro Atlanta locations for easy access to care.

Frequently Asked Questions

Will I feel the device under my skin?

Altaviva is very small and sits flat above the fascia near the ankle. Most patients forget it's there after the incision heals. It does not interfere with walking, wearing shoes, or normal activities.

How is Altaviva different from eCoin?

Both are implantable tibial nerve stimulators placed near the ankle. Altaviva offers a much longer battery life (15 years vs. ~3 years), MRI compatibility from day one, rechargeable technology (1-2 charges per year), and is backed by Medtronic's extensive neuromodulation platform. eCoin is non-rechargeable and requires full device replacement after approximately 3 years.

Can I get an MRI with Altaviva?

Yes. Altaviva is MRI-ready from the day of implantation and compatible with both 1.5T and 3T full-body MRI scans. Always carry your device ID card and inform the MRI technologist.

How long does the procedure take?

The implantation takes approximately 15-20 minutes and is performed in the office under local anesthesia. No sedation, imaging, or hospital visit is required. Therapy is activated the same day.

How often do I need to recharge?

Under standard settings, recharging is needed only 1-2 times per year. Each session takes about 30 minutes using a small external charger placed over the ankle area. The battery is expected to last up to 15 years.

What if Altaviva doesn't work for me?

If you don't achieve adequate symptom relief, the device can be removed with a simple procedure. We then discuss alternative treatments such as InterStim, Botox injections, or other options tailored to your needs.

Is Altaviva covered by insurance?

Coverage varies by plan. As a newly FDA-approved Medtronic device, insurance coverage is being established. Our team will verify your coverage and obtain prior authorization before scheduling your procedure.

Can I exercise and swim with Altaviva?

Yes. After the initial 1-week healing period, you can resume all normal activities including exercise, swimming, and sports. The device is implanted under the skin and designed for an active lifestyle.

Next Steps

If you're living with urge urinary incontinence and want a long-lasting, minimally invasive treatment that works automatically with virtually no daily involvement, Altaviva may be the right option for you. Our specialists will help you understand all your options and find the best path forward.